Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.3, 2009-01, pp. : 247-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers

By Howard Paul

PharmacoEconomics, Vol. 26, Iss. 6, 2008-01 ,pp. : 497-511

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation: A BENESCO Markov Cost-Effectiveness Analysis

By Annemans Lieven

Clinical Drug Investigation, Vol. 29, Iss. 10, 2009-10 ,pp. : 655-665

Adis International

Access to resources Recommend Favorite

Varenicline: progress in smoking cessation treatment

By Glover Elbert D Rath Jessica M

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1757-1767

Informa Healthcare

Access to resources Recommend Favorite

Varenicline: A Novel Pharmacotherapy for Smoking Cessation

By Jiménez-Ruiz Carlos

Drugs, Vol. 69, Iss. 10, 2009-07 ,pp. : 1319-1338

Adis International

Access to resources Recommend Favorite

A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

By Xenakis James G.

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 497-510

Adis International

Access to resources Recommend Favorite